Virtual cardiometabolic care solution designer company, Vida Health has published the results of a study that has demonstrated dramatic improvements in glycemic control of users who participated in Vida’s interactive digital health diabetes management program. The results also highlighted an important relationship between the improved management of depression and diabetes.
The Study
The study used a single-arm, retrospective design. Patients enrolled used the app-based intervention with one-on-one remote sessions. These sessions took place with a health coach, registered dietitian nutritionist and/or certified diabetes care and education specialist.
Users received structured lessons and tools related to diabetes management and self-care. Participants provided baseline HbA1C values and follow-up values at least 90 days after starting the program.
The Results
For patients with baseline HbA1C of >/= 9, the study showed an average 1.9-point reduction in HbA1C at four months and sustained for one year. For those with baseline HbA1C of >/= 9, participants showed a 1.4-point reduction at four months, also sustained for one year.
Participants who saw improvements in depression acuity registered nearly two times greater improvements in HbA1C. Additionally, 61% of participants saw a downward shift in depression acuity, while 55% saw a downward shift in anxiety acuity.
Vida’s platform also demonstrated proven clinical outcomes across a range of conditions, including diabetes, depression, hypertension, anxiety, and weight loss.
The article highlighting the study and the results was published in the journal JMIR Formative Research.
Join the HealthXL Meeting on ‘Digital Biomarkers for Mental Health Evaluation and Management’ on 16th February. Click here to Request to Join.
Click here to read the complete study.